Trial intelligence / Profile preview

Probiotics vs DAP vs Calcium Hydroxide for Postoperative Pain in Irreversible Pulpitis

NCT07270159Completed

Sponsor
Dow University of Health Sciences
Start
Jun 2025
Primary completion
Oct 2025
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, double-blind trial of Lactobacillus rhamnosus GG in postoperative pain (3 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Postoperative Pain Intensity at 7 days. Started Jun 2025; status: completed.

02

Drugs

Lactobacillus rhamnosus GG
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07270159.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07270159.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call